Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Evolent Health ( (EVH) ) has shared an update.
On February 3, 2025, Evolent Health entered into a Cooperation Agreement with Engaged Capital, resulting in the appointment of Brendan Springstubb to its Board of Directors. Additionally, M. Bridget Duffy resigned from the Board, not due to any disagreements. These changes are part of Evolent’s ongoing corporate governance enhancement efforts, highlighted by the upcoming appointment of Richard Jelinek as Chair of the Board at the 2025 Annual Meeting and the search for a new independent director. The agreement with Engaged Capital includes standstill restrictions and stipulations regarding voting and nominations, aimed at ensuring strong shareholder collaboration and enhancing Evolent’s competitive position in the healthcare industry.
More about Evolent Health
Evolent Health specializes in improving health outcomes for individuals with complex conditions through solutions that simplify and reduce healthcare costs. It serves a nationwide clientele of leading payers and providers and is recognized as an excellent workplace in the healthcare sector.
YTD Price Performance: -9.05%
Average Trading Volume: 2,822,880
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.22B
Learn more about EVH stock on TipRanks’ Stock Analysis page.
